These data suggest that deficient Rnf43 and mutant Kras synergistically promote mouse pancreatic tumorigenesis, which mimics the cardinal features of human IPMN. The gene discussed is RNF43; the disease is pancreatic intraductal papillary-mucinous neoplasm.